Neuroprotection in arterial hypertension and cognitive impairment

Announcement:

In a new video lecture, Professor V.V. Tyrenko presented a comprehensive analysis of one of the key issues in cardio-neurology: neuroprotective strategies for patients with arterial hypertension and cognitive impairment. The path from risk factors to evidence-based therapy is explored.

Key blocks:

•         Hypertension and dementia: Established pathogenetic links and the role of hypertension as a controllable risk factor.
•         Patient management: Current algorithms for diagnosis and management of cognitive dysfunction and vascular dementia.
•         Chronic cerebral ischemia (CCI): Current classification, risk factors and the critical role of lifestyle factors.
•         Diagnosis of cognitive deficit: A review of practical tests and scales for neuropsychological testing in clinical practice.
•         Inflammation and cognitive impairment: A modern view on the role of systemic inflammation and neuroinflammation in the pathogenesis of cognitive impairment.
•         Resolution of the expert council on the use of neuroprotectors in hypertension and analysis of the evidence base.
•         The place of the drug Mexidol® based on clinical trial data, mechanisms of action and expected neuroprotective effects in the context of pathogenetic treatment.

Why is this lecture important?
This material combines cutting-edge scientific concepts (inflammaging, evidence-based neuroprotection) with specific practical recommendations. You'll gain not only an understanding of the problem but also a clear action plan: from screening the cognitive status of patients with hypertension and cognitive impairment to informed treatment choices based on the latest expert consensus.